IMPLANT SCIENCES CORP
IMX
IMX was delisted on the 3rd of April, 2009.
3 hedge funds and large institutions have $49K invested in IMPLANT SCIENCES CORP in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
32% more capital invested
Capital invested by funds: $37K → $49K (+$12K)
0% more funds holding
Funds holding: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Regent Investment Management
Louisville,
Kentucky
|
+$15.2K |
Top Sellers
IMX Hedge Fund Activity: Q4 2014 in Review
3 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in IMPLANT SCIENCES CORP (IMX) for Q4 2014, worth a combined $49K — up 32% from $37K a quarter earlier.
Fund positioning in IMX was balanced in Q4 2014: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Regent Investment Management, adding an estimated $15.2K.
- 3 institutional investors held IMPLANT SCIENCES CORP (IMX) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $49K of IMPLANT SCIENCES CORP stock for Q4 2014, up 32% quarter-over-quarter.
- 0 funds opened new IMPLANT SCIENCES CORP positions in Q4 2014 and 0 closed out.
- The largest IMPLANT SCIENCES CORP buyer in Q4 2014 was Regent Investment Management, an estimated $15.2K added.
Based on aggregated 13F filings for Q4 2014.